A new study from JAMA has found that healthcare spending in the United States is nearly double that of 10 high-income countries yet still underperformed on many population health outcomes—with prices and administrative costs as the main driver of the differences in spending.
“Health Care Spending in the United States and Other High-Income Countries” says there is little evidence that efforts to reform U.S. healthcare delivery have been much help in curbing spending. The study concludes that targeting utilization alone is not enough to reduce growth in healthcare spending, so a more concerted effort is needed to reduce prices of labor and goods, including drugs and devices, and administrative costs.
JAMA compared potential drivers of spending in the United States with 10 of the highest-income countries (United Kingdom, Canada, Germany, Australia, Japan, Sweden, France, the Netherlands, Switzerland, and Denmark) to gain insight and see what the United States can learn from these nations.
“As patients, physicians, policymakers, and legislators actively debate the future of the U.S. health system, data such as these are needed to inform policy decisions,” the study says.
With LUMEDX’s CV performance improvement software, hospitals can collect point-of-care data and get actionable insights that facilitate better clinical decision-making and improve operations. Learn more about how you can increase efficiency and lower costs with HealthView Analytics and the Cardiovascular Performance Program (CPP) by visiting lumedx.com/healthview-analytics.